Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl G Hofbauer

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Discovery|March 16, 2013
Academic institutions and industry: bridging the gapKarl G Hofbauer
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|October 11, 2003
Stimulation of NPY Y2 receptors by PYY3-36 reveals divergent cardiovascular effects of endogenous NPY in rats on different dietary regimensUlrich Nordheim, Karl G Hofbauer
Annual Review of Pharmacology and Toxicology|September 28, 2006
The obesity epidemic: current and future pharmacological treatmentsKarl G Hofbauer, Janet R Nicholson, Olivier Boss
Nutrition (Burbank, Los Angeles County, Calif.)|July 30, 2008
Antibodies as pharmacologic tools for studies on the regulation of energy balanceKarl G Hofbauer, Anne-Catherine Lecourt, Jean-Christophe Peter
European Journal of Pharmacology|October 11, 2005
Central administration of small interfering RNAs in rats: a comparison with antisense oligonucleotidesClaudia Senn, Christoph Hangartner, Suzette Moes, et al.
Peptides|November 9, 2005
Cardiovascular responses to melanocortin 4-receptor stimulation in conscious unrestrained normotensive ratsUlrich Nordheim, Janet R Nicholson, Karol Dokladny, et al.
Journal of Receptor and Signal Transduction Research|November 25, 2010
Antibodies raised against different extracellular loops of the melanocortin-3 receptor affect energy balance and autonomic function in ratsJean-Christophe Peter, Géraldine Zipfel, Anne-Catherine Lecourt, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 27, 2006
Peripheral administration of a melanocortin 4-receptor inverse agonist prevents loss of lean body mass in tumor-bearing miceJanet R Nicholson, Götz Kohler, Florian Schaerer, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 27, 2007
Antibodies against the melanocortin-4 receptor act as inverse agonists in vitro and in vivoJean-Christophe Peter, Janet R Nicholson, Déborah Heydet, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 2, 2010
A pharmacologically active monoclonal antibody against the human melanocortin-4 receptor: effectiveness after peripheral and central administrationJean-Christophe Peter, Anne-Catherine Lecourt, Marjorie Weckering, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Discovery|March 16, 2013
Academic institutions and industry: bridging the gapKarl G Hofbauer
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|October 11, 2003
Stimulation of NPY Y2 receptors by PYY3-36 reveals divergent cardiovascular effects of endogenous NPY in rats on different dietary regimensUlrich Nordheim, Karl G Hofbauer
Annual Review of Pharmacology and Toxicology|September 28, 2006
The obesity epidemic: current and future pharmacological treatmentsKarl G Hofbauer, Janet R Nicholson, Olivier Boss
Nutrition (Burbank, Los Angeles County, Calif.)|July 30, 2008
Antibodies as pharmacologic tools for studies on the regulation of energy balanceKarl G Hofbauer, Anne-Catherine Lecourt, Jean-Christophe Peter
European Journal of Pharmacology|October 11, 2005
Central administration of small interfering RNAs in rats: a comparison with antisense oligonucleotidesClaudia Senn, Christoph Hangartner, Suzette Moes, et al.
Peptides|November 9, 2005
Cardiovascular responses to melanocortin 4-receptor stimulation in conscious unrestrained normotensive ratsUlrich Nordheim, Janet R Nicholson, Karol Dokladny, et al.
Journal of Receptor and Signal Transduction Research|November 25, 2010
Antibodies raised against different extracellular loops of the melanocortin-3 receptor affect energy balance and autonomic function in ratsJean-Christophe Peter, Géraldine Zipfel, Anne-Catherine Lecourt, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 27, 2006
Peripheral administration of a melanocortin 4-receptor inverse agonist prevents loss of lean body mass in tumor-bearing miceJanet R Nicholson, Götz Kohler, Florian Schaerer, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 27, 2007
Antibodies against the melanocortin-4 receptor act as inverse agonists in vitro and in vivoJean-Christophe Peter, Janet R Nicholson, Déborah Heydet, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 2, 2010
A pharmacologically active monoclonal antibody against the human melanocortin-4 receptor: effectiveness after peripheral and central administrationJean-Christophe Peter, Anne-Catherine Lecourt, Marjorie Weckering, et al.
Pageof 2